I don't drink, but I'm looking forward to a cocktail. The nice thing about that is that our market will be increased beyond lenz being used just as a therapeutic, but also used by totally asymptomatic people trying to protect themselves from covid by taking a Nuvaxovid vaccine with lenz.
Maybe this is why the EU wants to look at additional Novavax data over the next four weeks or so.